Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Double chemo attack may stall tough prostate cancer

NCT ID NCT06470243

Disease control Sponsor: SWOG Cancer Research Network Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This phase III trial tests whether adding carboplatin to the standard chemo drug cabazitaxel helps men with metastatic castrate-resistant prostate cancer live longer without their cancer worsening. About 528 men will be randomly assigned to get cabazitaxel alone or cabazitaxel plus carboplatin. The study focuses on men whose tumors have a specific aggressive genetic signature.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
cabazitaxel and carboplatin (chemotherapy drugs)
What this could lead to
If it works, this combination could slow cancer growth better than standard treatment alone for men with aggressive prostate cancer.
What could go wrong
This is a large phase III trial, but adding carboplatin may increase side effects without improving outcomes. Results are not guaranteed.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Phase 3

Large-scale testing in a bigger group. Usually the last step before a treatment can be approved.

Participants

About 528 people

The number the study aims to enrol. It can still change while the study runs.

Started

Nov 2024

Expected to finish

Apr 2034

An estimate. End dates often move.

Lead sponsor

A research network

The lead sponsor is a research network or cooperative group.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Male participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * STEP 1 SCREENING REGISTRATION: NOTE: All participants must have biopsy tissue submitted to MD Anderson Cancer Center prior to randomization for alteration assessment. Participants must have determination of their AVPC-Molecular Pathologic Signature immunohistochemistry (MSIHC) status from central assessment by the MD Anderson Clinical Pathology Laboratory using Clinical Laboratory Improvement Act (CLIA) certified immunohistochemistry (IHC) assays for TP53, RB1 and PTEN. In addition, while not mandated, CLIA certified next generation sequencing (NGS) of tumor deoxyribonucleic acid (DNA) and/or circulating tumor derived DNA (ctDNA) assessment of AVPC-MS marker status will be collected from participants for whom it is available * STEP 1 SCREENING REGISTRATION: Participants must have a histologically confirmed diagnosis of prostate cancer at the time of step 1 registration * STEP 1 SCREENING REGISTRATION: Participants must have castrate-resistant prostate cancer and metastatic disease by bone scan and/or CT/MRI (i.e., soft tissue, visceral, lymph node) * STEP 1 SCREENING REGISTRATION: Participants may have received any prior therapy, but one must be docetaxel or contain docetaxel in either the castrate-sensitive and/or castrate resistant disease state * STEP 1 SCREENING REGISTRATION: Participants must be ≥ 18 years of age at the time of step 1 screening registration * STEP 1 SCREENING REGISTRATION: Participants must have solid tumor biopsy material (formalin-fixed paraffin-embedded (FFPE) tissue blocks and/or 10 cut slides on four-micron thick unstained positive charged slides of FFPE tissue) available for submission for alterations in TP53, RB1 and PTEN by IHC using CLIA certified assays in the MD Anderson Clinical Pathology Laboratory. This specimen is required for central assessment of the AVPC-MSIHC regardless of whether the site has already locally evaluated the AVPC-MS status * STEP 1 SCREENING REGISTRATION: Tumor samples submitted for analysis must have been collected within 12 months prior to step 1 screening registration. Samples from metastatic lesions collected in the castrate-resistant disease state are preferable but not mandatory. Samples obtained during the hormone-naive disease state are acceptable if collected within 12 months of step 1 screening registration. If more than one tumor sample exists, the sample obtained closest to the date of registration should be submitted to MDACC for analysis * NOTE: Sites will receive an email from Southwest Oncology Group (SWOG) Statistics and Data Management Center containing participant results of Aggressive Variant Prostate Cancer Molecular Signature (AVPC-MS) assessment within 5-12 business days after tissue submission to MD Anderson Clinical Pathology Laboratory. The participant's AVPC-MS signature result (positive or negative) is required BEFORE randomization on to step 2. If sites receive a non-evaluable AVPC-MS signature result, SWOG Statistics and Data Management Center will provide instructions for resubmission * STEP 1 SCREENING REGISTRATION: NOTE: As a part of the Oncology Patient Enrollment Network (OPEN) registration process the treating institution's identity is provided in order to ensure that the current (within 365 days) date of institutional review board approval for this study has been entered in the system * STEP 1 SCREENING REGISTRATION: Participants must be informed of the investigational nature of this study and must sign and give informed consent in accordance with institutional and federal guidelines. Documentation of informed consent via remote consent is allowed * For participants with impaired decision-making capabilities, legally authorized representatives may sign and give informed consent on behalf of study participants in accordance with applicable federal, local, and Central Institutional Review Board (CIRB) regulations * STEP 2 RANDOMIZATION: NOTE: Participants must be registered to step 2 randomization within 70 days after registration to step 1. Participants must plan to start protocol therapy no more than 14 days after step 2 randomization * STEP 2 RANDOMIZATION: Participants must have castrate levels of testosterone with a baseline level \< 50ng/dL within 28 days prior to step 2 randomization * STEP 2 RANDOMIZATION: Participants must have evidence for metastatic prostate cancer by bone scan and/or CT/MRI (i.e., soft tissue, visceral, lymph node). Visceral and/or soft-tissue metastases must be ≥ 1.0 cm in diameter and lymph nodes must be \> 1.5 cm diameter in the short axis. Scans must be obtained within 28 days prior to randomization * NOTE: All disease must be assessed and documented on the baseline/pre-registration tumor assessment form * STEP 2 RANDOMZIATION: Participants must have progressive disease (PD) in the opinion of the treating investigator according to any of the following criteria * Progression in measurable disease (RECIST 1.1 criteria). Patient with measurable disease must have at least one lesion that can be accurately measured in at least one dimension (longest diameter to be recorded). Each lesion must be at least 10 mm when measured by computed tomography (CT) \[CT scan thickness no greater than 5 mm\] or magnetic resonance imaging (MRI). Lymph nodes should be ≥ 15 mm in short axis. Previously irradiated lesions, primary prostate lesion and bone lesions will be considered non-measurable disease * Progression in bone as evidenced by: * Appearance of 2 or more new bone lesions on bone scan (BS). If equivocal, they must be confirmed by other imaging modalities (CT; MRI), and/or repeat BS \> 4 weeks later * Appearance of a new lytic lesion(s) and/or increasing size of an existing lesion by CT/MRI, since AVPC tumors may produce lytic bone lesions that are not detected on conventional bone scans * Rising prostate-specific antigen (PSA) defined (Prostate Cancer Working Group 2 \[PCWG2\]) as at least two consecutive rises in PSA to be documented over a reference value (measure 1) taken at least one week apart. The first rising PSA (measure 2) should be taken at least 7 days after the reference value. A third confirmatory PSA measure is required (2nd beyond the reference level) to be greater than the second measure and it must be obtained at least 7 days after the 2nd measure. If this is not the case, a fourth PSA measure is required to be taken and be greater than the 2nd measure. In case of progression based on rising PSA only, the first rising PSA (measure 2) must be obtained within 6 months of initiation of androgen receptor (AR) targeted therapy (≤ 6 months) * Clinical progression. Increasing symptoms unequivocally attributed to disease progression as judged by the treating physician * STEP 2 RANDOMIZATION: Participants must not have received prior cabazitaxel or carboplatin * STEP 2 RANDOMIZATION: Participants must not be receiving treatment on another therapeutic clinical trial at the time of randomization. Chemotherapies, bone targeting therapies, immunotherapies and clinical trial agents must be discontinued ≥ 21 days prior to randomization. Stereotactic radiation (SART) must be discontinued ≥ 3 days prior to randomization * STEP 2 RANDOMIZATION: Participants must not be receiving radiation therapy or kyphoplasty-vertebroplasty within 14 days prior to randomization or major surgery (e.g., open abdominal, pelvic, thoracic, orthopedic or neurosurgery) within 28 days prior to step 2 randomization * STEP 2 RANDOMIZATION: Participants must not have untreated fractures and/or cord compression * STEP 2 RANDOMIZATION: Participants must not have symptomatic uncontrolled brain metastases. Properly treated brain metastases (i.e., with stereotactic radiation) within 14 days are allowed * STEP 2 RANDOMIZATION: Participants must have Zubrod performance status of 0 - 2 within 28 days prior to step 2 randomization * STEP 2 RANDOMIZATION: Participants must have a complete medical history and physical exam within 28 days prior to step 2 randomization * STEP 2 RANDOMIZATION: Absolute neutrophil count ≥ 1.5 x 10\^3/uL (within 28 days prior to step 2 randomization) * STEP 2 RANDOMIZATION: Platelets ≥ 100 x 10\^3/uL (unless clinical evidence of bone marrow infiltration by tumor in which case \> 75 x 10\^3/uL are allowed) (within 28 days prior to step 2 randomization) * STEP 2 RANDOMIZATION: Total bilirubin ≤ institutional upper limit of normal (ULN) with the exception of isolated hyperbilirubinemia due to Gilbert's syndrome or if the participant has liver metastases and/or acute tumor associated illness \< 4x ULN (within 28 days prior to step 2 randomization) * STEP 2 RANDOMIZATION: Aspartate aminotransferase (AST)/alanine aminotransferase (ALT) ≤ 3 × institutional ULN (or if participant has liver metastases and/or acute tumor-associated illness, ≤ 4x institutional ULN) (within 28 days prior to step 2 randomization) * STEP 2 REGISTRATION: Participants must have a calculated creatinine clearance ≥ 30 mL/min using the Cockcroft-Gault Formula. This specimen must have been drawn and processed within 28 days prior to step 2 randomization * STEP 2 RANDOMIZATION: Participants with peripheral neuropathy must have ≤ grade 2 peripheral neuropathy (Common Terminology Criteria for Adverse Events \[CTCAE\] version 5.0) (within 28 days prior to step 2 randomization) * STEP 2 RANDOMIZATION: Participants who are of reproductive potential must have agreed to use an effective contraceptive method with details provided as a part of the consent process. A person who has semen likely to contain sperm is considered to be of "reproductive potential." In addition to routine contraceptive methods, "effective contraception" also includes refraining from sexual activity that might result in pregnancy and surgery intended to prevent pregnancy (or with a side-effect of pregnancy prevention) including vasectomy with testing showing no sperm in the semen * STEP 2 RANDOMIZATION: Participants must not have a prior or concurrent malignancy whose natural history or treatment (in the opinion of the treating physician) has the potential to interfere with the safety or efficacy assessment of the treatment regimen * STEP 2 RANDOMIZATION: Participants with known human immunodeficiency virus (HIV)-infection must be on effective anti-retroviral therapy at registration and have undetectable viral load test on the most recent test results obtained within 6 months prior to registration * STEP 2 RANDOMIZATION: Participants must be offered the opportunity to participate in specimen banking. With participant consent, specimens must be collected and submitted via the SWOG Specimen Tracking System

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Castration-resistant prostate carcinoma are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

castration-resistant prostate carcinoma metastatic prostate carcinoma prostate cancer

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Castration-resistant prostate carcinoma Stage IVB prostate cancer ajcc V8

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The study's own enquiry address

    This study publishes an address for enquiries. See it below .

  2. The places running it

    174 sites. The list below names each one and where it is.

  3. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  4. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Abbott-Northwestern Hospital

    RECRUITING

    Minneapolis, Minnesota, 55407, United States

  • Armes Family Cancer Center

    RECRUITING

    Findlay, Ohio, 45840, United States

    Contact Email: •••••@•••••

  • BJC Outpatient Center at Sunset Hills

    RECRUITING

    Sunset Hills, Missouri, 63127, United States

  • Beebe Health Campus

    RECRUITING

    Rehoboth Beach, Delaware, 19971, United States

    Contact Email: •••••@•••••

  • Beebe Medical Center

    RECRUITING

    Lewes, Delaware, 19958, United States

    Contact Email: •••••@•••••

  • Beebe South Coastal Health Campus

    RECRUITING

    Millville, Delaware, 19967, United States

    Contact Email: •••••@•••••

  • Benefis Sletten Cancer Institute

    RECRUITING

    Great Falls, Montana, 59405, United States

    Contact Email: •••••@•••••

  • Billings Clinic Cancer Center

    RECRUITING

    Billings, Montana, 59101, United States

    Contact Email: •••••@•••••

  • Billings Clinic-Cody

    RECRUITING

    Cody, Wyoming, 82414, United States

    Contact Email: •••••@•••••

  • Blanchard Valley Hospital

    RECRUITING

    Findlay, Ohio, 45840, United States

    Contact Email: •••••@•••••

  • Bozeman Health Deaconess Hospital

    RECRUITING

    Bozeman, Montana, 59715, United States

    Contact Email: •••••@•••••

  • Cambridge Medical Center

    RECRUITING

    Cambridge, Minnesota, 55008, United States

  • Cancer Care Center of O'Fallon

    RECRUITING

    O'Fallon, Illinois, 62269, United States

  • Cancer Care Specialists of Illinois - Decatur

    RECRUITING

    Decatur, Illinois, 62526, United States

  • Cancer Center of Western Wisconsin

    RECRUITING

    New Richmond, Wisconsin, 54017, United States

  • Caro Cancer Center

    RECRUITING

    Caro, Michigan, 48723, United States

  • Centralia Oncology Clinic

    RECRUITING

    Centralia, Illinois, 62801, United States

  • Chelsea Hospital

    RECRUITING

    Chelsea, Michigan, 48118, United States

  • Christiana Care - Union Hospital

    RECRUITING

    Elkton, Maryland, 21921, United States

  • Christiana Care Health System-Christiana Hospital

    RECRUITING

    Newark, Delaware, 19718, United States

  • Christiana Care Health System-Concord Health Center

    RECRUITING

    Chadds Ford, Pennsylvania, 19317, United States

  • Christiana Care Health System-Wilmington Hospital

    RECRUITING

    Wilmington, Delaware, 19801, United States

  • Community Hospital of Anaconda

    RECRUITING

    Anaconda, Montana, 59711, United States

    Contact Email: •••••@•••••

  • Community Medical Center

    RECRUITING

    Missoula, Montana, 59804, United States

    Contact Email: •••••@•••••

  • Crossroads Cancer Center

    RECRUITING

    Effingham, Illinois, 62401, United States

  • Dayton Physician LLC - Englewood

    RECRUITING

    Dayton, Ohio, 45415, United States

    Contact Email: •••••@•••••

  • Dayton Physicians LLC - Troy

    RECRUITING

    Troy, Ohio, 45373, United States

    Contact Email: •••••@•••••

  • Dayton Physicians LLC-Atrium

    RECRUITING

    Franklin, Ohio, 45005, United States

    Contact Email: •••••@•••••

  • Dayton Physicians LLC-Miami Valley South

    RECRUITING

    Centerville, Ohio, 45459, United States

    Contact Email: •••••@•••••

  • Dayton Physicians LLC-Wayne

    RECRUITING

    Greenville, Ohio, 45331, United States

    Contact Email: •••••@•••••

  • Decatur Memorial Hospital

    RECRUITING

    Decatur, Illinois, 62526, United States

  • Fairview Clinics and Surgery Center Maple Grove

    RECRUITING

    Maple Grove, Minnesota, 55369, United States

  • Fairview Lakes Medical Center

    RECRUITING

    Wyoming, Minnesota, 55092, United States

  • Fairview Northland Medical Center

    RECRUITING

    Princeton, Minnesota, 55371, United States

  • Fairview Southdale Hospital

    RECRUITING

    Edina, Minnesota, 55435, United States

  • Genesee Cancer and Blood Disease Treatment Center

    RECRUITING

    Flint, Michigan, 48503, United States

  • Genesee Hematology Oncology PC

    RECRUITING

    Flint, Michigan, 48503, United States

  • Genesys Hurley Cancer Institute

    RECRUITING

    Flint, Michigan, 48503, United States

  • Great Falls Clinic

    RECRUITING

    Great Falls, Montana, 59405, United States

    Contact Email: •••••@•••••

  • Great Lakes Cancer Management Specialists-Doctors Park

    RECRUITING

    East China Township, Michigan, 48054, United States

  • Great Lakes Cancer Management Specialists-Macomb Medical Campus

    RECRUITING

    Macomb, Michigan, 48044, United States

  • Great Lakes Cancer Management Specialists-Macomb Professional Building

    RECRUITING

    Warren, Michigan, 48093, United States

  • Great Lakes Cancer Management Specialists-Van Elslander Cancer Center

    RECRUITING

    Grosse Pointe Woods, Michigan, 48236, United States

  • Greater Dayton Cancer Center

    RECRUITING

    Kettering, Ohio, 45409, United States

    Contact Email: •••••@•••••

  • HSHS Saint Elizabeth's Hospital

    RECRUITING

    O'Fallon, Illinois, 62269, United States

  • Health Partners Inc

    RECRUITING

    Minneapolis, Minnesota, 55454, United States

  • Helen F Graham Cancer Center

    RECRUITING

    Newark, Delaware, 19713, United States

  • Hematology Oncology Consultants-Clarkston

    RECRUITING

    Clarkston, Michigan, 48346, United States

  • Hennepin County Medical Center

    RECRUITING

    Minneapolis, Minnesota, 55415, United States

  • Henry Ford Health Saint John Hospital

    RECRUITING

    Detroit, Michigan, 48236, United States

  • Henry Ford Madison Heights Hospital - Breast

    RECRUITING

    Warren, Michigan, 48093, United States

  • Henry Ford Saint John Hospital - Academic

    RECRUITING

    Grosse Pointe Woods, Michigan, 48236, United States

  • Henry Ford Saint John Hospital - Breast

    RECRUITING

    Grosse Pointe Woods, Michigan, 48236, United States

  • Henry Ford Warren Hospital - Breast Macomb

    RECRUITING

    Macomb, Michigan, 48044, United States

  • Highlands Oncology Group

    RECRUITING

    Springdale, Arkansas, 72762, United States

    Contact Email: •••••@•••••

  • Highlands Oncology Group - Fayetteville

    RECRUITING

    Fayetteville, Arkansas, 72703, United States

    Contact Email: •••••@•••••

  • Highlands Oncology Group - Rogers

    RECRUITING

    Rogers, Arkansas, 72758, United States

    Contact Email: •••••@•••••

  • Holy Cross Hospital

    RECRUITING

    Fort Lauderdale, Florida, 33308, United States

  • Hope Cancer Center

    RECRUITING

    Pontiac, Michigan, 48341, United States

  • Hurley Medical Center

    RECRUITING

    Flint, Michigan, 48503, United States

  • Huron Gastroenterology PC

    RECRUITING

    Ypsilanti, Michigan, 48106, United States

  • Idaho Urologic Institute-Meridian

    RECRUITING

    Meridian, Idaho, 83642, United States

  • Illinois CancerCare - Washington

    RECRUITING

    Washington, Illinois, 61571, United States

  • Illinois CancerCare-Bloomington

    RECRUITING

    Bloomington, Illinois, 61704, United States

  • Illinois CancerCare-Canton

    RECRUITING

    Canton, Illinois, 61520, United States

  • Illinois CancerCare-Carthage

    RECRUITING

    Carthage, Illinois, 62321, United States

  • Illinois CancerCare-Dixon

    RECRUITING

    Dixon, Illinois, 61021, United States

  • Illinois CancerCare-Eureka

    RECRUITING

    Eureka, Illinois, 61530, United States

  • Illinois CancerCare-Galesburg

    RECRUITING

    Galesburg, Illinois, 61401, United States

  • Illinois CancerCare-Kewanee Clinic

    RECRUITING

    Kewanee, Illinois, 61443, United States

  • Illinois CancerCare-Macomb

    RECRUITING

    Macomb, Illinois, 61455, United States

  • Illinois CancerCare-Ottawa Clinic

    RECRUITING

    Ottawa, Illinois, 61350, United States

  • Illinois CancerCare-Pekin

    RECRUITING

    Pekin, Illinois, 61554, United States

  • Illinois CancerCare-Peoria

    RECRUITING

    Peoria, Illinois, 61615, United States

  • Illinois CancerCare-Peru

    RECRUITING

    Peru, Illinois, 61354, United States

  • Illinois CancerCare-Princeton

    RECRUITING

    Princeton, Illinois, 61356, United States

  • Indu and Raj Soin Medical Center

    RECRUITING

    Beavercreek, Ohio, 45431, United States

    Contact Email: •••••@•••••

  • Kalispell Regional Medical Center

    RECRUITING

    Kalispell, Montana, 59901, United States

    Contact Email: •••••@•••••

  • Kettering Medical Center

    RECRUITING

    Kettering, Ohio, 45429, United States

    Contact Email: •••••@•••••

  • Kootenai Clinic Cancer Services - Post Falls

    RECRUITING

    Post Falls, Idaho, 83854, United States

    Contact Email: •••••@•••••

  • Kootenai Clinic Cancer Services - Sandpoint

    RECRUITING

    Sandpoint, Idaho, 83864, United States

    Contact Email: •••••@•••••

  • Kootenai Health - Coeur d'Alene

    RECRUITING

    Coeur d'Alene, Idaho, 83814, United States

    Contact Email: •••••@•••••

  • Lakeview Hospital

    RECRUITING

    Stillwater, Minnesota, 55082, United States

  • Lehigh Valley Hospital - Muhlenberg

    RECRUITING

    Bethlehem, Pennsylvania, 18017, United States

  • Lehigh Valley Hospital-Cedar Crest

    RECRUITING

    Allentown, Pennsylvania, 18103, United States

  • Lehigh Valley Hospital-Hazleton

    RECRUITING

    Hazleton, Pennsylvania, 18201, United States

  • Lyndon Baines Johnson General Hospital

    RECRUITING

    Houston, Texas, 77026-1967, United States

  • M D Anderson Cancer Center

    RECRUITING

    Houston, Texas, 77030, United States

  • MD Anderson League City

    RECRUITING

    League City, Texas, 77573, United States

  • MD Anderson West Houston

    RECRUITING

    Houston, Texas, 77079, United States

  • MD Anderson in Sugar Land

    RECRUITING

    Sugar Land, Texas, 77478, United States

  • MD Anderson in The Woodlands

    RECRUITING

    Conroe, Texas, 77384, United States

  • Medical Oncology Hematology Consultants PA

    RECRUITING

    Newark, Delaware, 19713, United States

  • Memorial Hospital of Carbondale

    RECRUITING

    Carbondale, Illinois, 62902, United States

    Contact Email: •••••@•••••

  • Memorial Medical Center

    RECRUITING

    Springfield, Illinois, 62781, United States

  • Mercy Hospital

    RECRUITING

    Cedar Rapids, Iowa, 52403, United States

  • Mercy Hospital

    RECRUITING

    Coon Rapids, Minnesota, 55433, United States

  • Methodist Medical Center of Illinois

    RECRUITING

    Peoria, Illinois, 61636, United States

  • Michigan Healthcare Professionals Pontiac

    RECRUITING

    Pontiac, Michigan, 48341, United States

  • Minnesota Oncology - Burnsville

    RECRUITING

    Burnsville, Minnesota, 55337, United States

  • Minnesota Oncology Hematology PA-Maplewood

    RECRUITING

    Maplewood, Minnesota, 55109, United States

  • Minnesota Oncology Hematology PA-Woodbury

    RECRUITING

    Woodbury, Minnesota, 55125, United States

  • Missouri Baptist Medical Center

    RECRUITING

    St Louis, Missouri, 63131, United States

  • Missouri Baptist Sullivan Hospital

    RECRUITING

    Sullivan, Missouri, 63080, United States

  • Monticello Cancer Center

    RECRUITING

    Monticello, Minnesota, 55362, United States

  • MyMichigan Medical Center Saginaw

    RECRUITING

    Saginaw, Michigan, 48601, United States

  • MyMichigan Medical Center Tawas

    RECRUITING

    Tawas City, Michigan, 48764, United States

  • Nebraska Medicine-Bellevue

    RECRUITING

    Bellevue, Nebraska, 68123, United States

  • Nebraska Medicine-Village Pointe

    RECRUITING

    Omaha, Nebraska, 68118, United States

  • New Ulm Medical Center

    RECRUITING

    New Ulm, Minnesota, 56073, United States

  • Newland Medical Associates-Clarkston

    RECRUITING

    Clarkston, Michigan, 48346, United States

  • Newland Medical Associates-Pontiac

    RECRUITING

    Pontiac, Michigan, 48341, United States

  • North Memorial Medical Health Center

    RECRUITING

    Robbinsdale, Minnesota, 55422, United States

  • Northwestern Medicine Cancer Center Delnor

    RECRUITING

    Geneva, Illinois, 60134, United States

  • Northwestern Medicine Cancer Center Kishwaukee

    RECRUITING

    DeKalb, Illinois, 60115, United States

  • Northwestern Medicine Cancer Center Warrenville

    RECRUITING

    Warrenville, Illinois, 60555, United States

  • Northwestern Medicine Glenview Outpatient Center

    RECRUITING

    Glenview, Illinois, 60026, United States

  • Northwestern Medicine Grayslake Outpatient Center

    RECRUITING

    Grayslake, Illinois, 60030, United States

  • Northwestern Medicine Lake Forest Hospital

    RECRUITING

    Lake Forest, Illinois, 60045, United States

    Contact Email: •••••@•••••

  • Northwestern Medicine Orland Park

    RECRUITING

    Orland Park, Illinois, 60462, United States

  • Northwestern University

    RECRUITING

    Chicago, Illinois, 60611, United States

    Contact Email: •••••@•••••

  • Oncology Associates at Mercy Medical Center

    RECRUITING

    Cedar Rapids, Iowa, 52403, United States

  • Oncology Hematology Associates of Saginaw Valley PC

    RECRUITING

    Saginaw, Michigan, 48604, United States

  • Oncology Hematology Care Inc-Kenwood

    RECRUITING

    Cincinnati, Ohio, 45236, United States

    Contact Email: •••••@•••••

  • Orion Cancer Care

    RECRUITING

    Findlay, Ohio, 45840, United States

    Contact Email: •••••@•••••

  • Park Nicollet Clinic - Saint Louis Park

    RECRUITING

    Saint Louis Park, Minnesota, 55416, United States

  • Parkland Health Center - Farmington

    RECRUITING

    Farmington, Missouri, 63640, United States

  • Pocono Medical Center

    RECRUITING

    East Stroudsburg, Pennsylvania, 18301, United States

  • Regions Hospital

    RECRUITING

    Saint Paul, Minnesota, 55101, United States

  • Reid Health

    RECRUITING

    Richmond, Indiana, 47374, United States

    Contact Email: •••••@•••••

  • Rice Memorial Hospital

    RECRUITING

    Willmar, Minnesota, 56201, United States

  • Ridgeview Medical Center

    RECRUITING

    Waconia, Minnesota, 55387, United States

  • SIH Cancer Institute

    RECRUITING

    Carterville, Illinois, 62918, United States

    Contact Email: •••••@•••••

  • Saint Alphonsus Cancer Care Center-Baker City

    RECRUITING

    Baker City, Oregon, 97814, United States

    Contact Email: •••••@•••••

  • Saint Alphonsus Cancer Care Center-Boise

    RECRUITING

    Boise, Idaho, 83706, United States

  • Saint Alphonsus Cancer Care Center-Caldwell

    RECRUITING

    Caldwell, Idaho, 83605, United States

  • Saint Alphonsus Cancer Care Center-Nampa

    RECRUITING

    Nampa, Idaho, 83687, United States

    Contact Email: •••••@•••••

  • Saint Alphonsus Cancer Care Center-Ontario

    RECRUITING

    Ontario, Oregon, 97914, United States

    Contact Email: •••••@•••••

  • Saint Elizabeth Boardman Hospital

    RECRUITING

    Boardman, Ohio, 44512, United States

    Contact Email: •••••@•••••

  • Saint Elizabeth Youngstown Hospital

    RECRUITING

    Youngstown, Ohio, 44501, United States

    Contact Email: •••••@•••••

  • Saint Francis Medical Center

    RECRUITING

    Cape Girardeau, Missouri, 63703, United States

  • Saint Francis Regional Medical Center

    RECRUITING

    Shakopee, Minnesota, 55379, United States

  • Saint John Macomb-Oakland Hospital

    RECRUITING

    Warren, Michigan, 48093, United States

  • Saint John's Hospital - Healtheast

    RECRUITING

    Maplewood, Minnesota, 55109, United States

  • Saint Joseph Warren Hospital

    RECRUITING

    Warren, Ohio, 44484, United States

    Contact Email: •••••@•••••

  • Saint Mary's Oncology/Hematology Associates of Marlette

    RECRUITING

    Marlette, Michigan, 48453, United States

  • Saint Mary's Oncology/Hematology Associates of West Branch

    RECRUITING

    West Branch, Michigan, 48661, United States

  • Sainte Genevieve County Memorial Hospital

    RECRUITING

    Sainte Genevieve, Missouri, 63670, United States

  • Southeast Cancer Center

    RECRUITING

    Cape Girardeau, Missouri, 63703, United States

  • Southern Illinois University School of Medicine

    RECRUITING

    Springfield, Illinois, 62702, United States

  • Springfield Clinic

    RECRUITING

    Springfield, Illinois, 62702, United States

  • The West Clinic - Wolf River

    RECRUITING

    Germantown, Tennessee, 38138, United States

  • Tibor Rubin VA Medical Center

    RECRUITING

    Long Beach, California, 90822, United States

  • Trinity Health IHA Medical Group Hematology Oncology - Brighton

    RECRUITING

    Brighton, Michigan, 48114, United States

  • Trinity Health IHA Medical Group Hematology Oncology - Canton

    RECRUITING

    Canton, Michigan, 48188, United States

  • Trinity Health IHA Medical Group Hematology Oncology - Chelsea Hospital

    RECRUITING

    Chelsea, Michigan, 48118, United States

  • Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus

    RECRUITING

    Ypsilanti, Michigan, 48197, United States

  • Trinity Health Medical Center - Brighton

    RECRUITING

    Brighton, Michigan, 48114, United States

  • Trinity Health Medical Center - Canton

    RECRUITING

    Canton, Michigan, 48188, United States

  • Trinity Health Saint Joseph Mercy Hospital Ann Arbor

    RECRUITING

    Ann Arbor, Michigan, 48106, United States

  • Trinity Health Saint Joseph Mercy Oakland Hospital

    RECRUITING

    Pontiac, Michigan, 48341, United States

  • Trinity Health Saint Mary Mercy Livonia Hospital

    RECRUITING

    Livonia, Michigan, 48154, United States

  • United Hospital

    RECRUITING

    Saint Paul, Minnesota, 55102, United States

  • University of Illinois

    RECRUITING

    Chicago, Illinois, 60612, United States

  • University of Michigan Health - Sparrow Lansing

    RECRUITING

    Lansing, Michigan, 48912, United States

  • University of Mississippi Medical Center

    RECRUITING

    Jackson, Mississippi, 39216, United States

  • University of Nebraska Medical Center

    RECRUITING

    Omaha, Nebraska, 68198, United States

  • University of Oklahoma Health Sciences Center

    RECRUITING

    Oklahoma City, Oklahoma, 73104, United States

  • VCU Massey Cancer Center at Stony Point

    RECRUITING

    Richmond, Virginia, 23235, United States

  • Valley Radiation Oncology

    RECRUITING

    Peru, Illinois, 61354, United States

  • Virginia Commonwealth University/Massey Cancer Center

    RECRUITING

    Richmond, Virginia, 23298, United States

  • Wayne Hospital

    RECRUITING

    Greenville, Ohio, 45331, United States

    Contact Email: •••••@•••••

  • Welch Cancer Center

    RECRUITING

    Sheridan, Wyoming, 82801, United States

    Contact Email: •••••@•••••

  • Western Illinois Cancer Treatment Center

    RECRUITING

    Galesburg, Illinois, 61401, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.